6-162443383-C-T
Variant summary
Our verdict is Likely pathogenic. Variant got 9 ACMG points: 10P and 1B. PM2PP5_Very_StrongBP4
The NM_004562.3(PRKN):c.98G>A(p.Arg33Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000154 in 1,613,848 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_004562.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PRKN | NM_004562.3 | c.98G>A | p.Arg33Gln | missense_variant | 2/12 | ENST00000366898.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PRKN | ENST00000366898.6 | c.98G>A | p.Arg33Gln | missense_variant | 2/12 | 1 | NM_004562.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152166Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000875 AC: 22AN: 251372Hom.: 0 AF XY: 0.0000736 AC XY: 10AN XY: 135852
GnomAD4 exome AF: 0.000164 AC: 240AN: 1461682Hom.: 0 Cov.: 33 AF XY: 0.000161 AC XY: 117AN XY: 727140
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152166Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74328
ClinVar
Submissions by phenotype
not provided Pathogenic:3
Likely pathogenic, criteria provided, single submitter | clinical testing | AiLife Diagnostics, AiLife Diagnostics | Sep 10, 2021 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | May 01, 2019 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 17, 2024 | This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 33 of the PRKN protein (p.Arg33Gln). This variant is present in population databases (rs147757966, gnomAD 0.02%). This missense change has been observed in individuals with early-onset Parkinson disease (PMID: 12730996, 16643317, 19636047). It has also been observed to segregate with disease in related individuals. This variant is also known as 199G>A. ClinVar contains an entry for this variant (Variation ID: 578186). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available". The glutamine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. Experimental studies have shown that this missense change affects PRKN function (PMID: 15606901, 21348451, 21694720, 23770917, 24647965, 26631732, 27534820). For these reasons, this variant has been classified as Pathogenic. - |
PRKN-related disorder Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 29, 2024 | The PRKN c.98G>A variant is predicted to result in the amino acid substitution p.Arg33Gln. This variant has been reported in the compound heterozygous state in individuals with both early- and late-onset Parkinson disease (Oliveira et al. 2003. PubMed ID: 12730996; Table e-1, Pankratz et al. 2009. PubMed ID: 19636047). Functional studies have shown that the p.Arg33Gln variant leads to lower steady-state levels of the PRKN protein (Henn et al. 2005. PubMed ID: 15606901) and reduce the ability of the Ubl domain of PRKN to become phosphorylated (Aguirre et al. 2018. PubMed ID: 29530980). Additional functional studies support the findings that the c.98G>A (p.Arg33Gln) variant impairs the function and stability of the PRKN protein (Chaugule et al. 2011. PubMed ID: 21694720; Safadi et al. 2011. PubMed ID: 21348451).This variant is reported in 0.016% of alleles in individuals of European (Non-Finnish) descent in gnomAD. Based on this evidence, this variant is interpreted as pathogenic. - |
Lung cancer;C0919267:Ovarian neoplasm;C1868675:Autosomal recessive juvenile Parkinson disease 2 Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Feb 09, 2022 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at